AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33851476 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrap-Type Holds
Number of subjects: 172
Study 32949091 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (Livact®) for up to 4 years
Number of subjects: 156
Study 32949091 — intervention group
Group type: COMPARATOR
Intervention: Surgery-alone
Number of subjects: 156
Study 33406472 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretomanid
Number of subjects: 0
Study 35180784 — intervention group
Group type: EXPERIMENTAL
Intervention: External dacryocystorhinostomy (EX-DCR)
Number of subjects: 60
Study 35180784 — intervention group
Group type: COMPARATOR
Intervention: Transcanalicular multidiode laser dacryocystorhinostomy (TDL-DCR)
Number of subjects: 60
Study 32457075 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg)
Number of subjects: 23
Study 32457075 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 23
Study 34162512 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Counseling + Memory Training (GC + MT)
Number of subjects: 124
Study 34162512 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Training (MT)
Number of subjects: 124
Study 34162512 — intervention group
Group type: COMPARATOR
Intervention: Group Counseling (GC)
Number of subjects: 124
Study 33342658 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aortic repair with aneurysm sac coil embolisation (ASCE)
Number of subjects: 94
Study 33342658 — intervention group
Group type: COMPARATOR
Intervention: Standard endovascular aortic repair (EVAR)
Number of subjects: 94
Study 33342658 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aortic repair with ASCE
Number of subjects: 94
Study 32883736 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted exercise-based fall prevention programme delivered by trained instructors
Number of subjects: 154
Study 32883736 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted exercise-based fall prevention programme
Number of subjects: 154
Study 34843806 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg dexamethasone with 0.5% ropivacaine and 0.2% lignocaine
Number of subjects: 66
Study 34843806 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) with 0.5% ropivacaine and 0.2% lignocaine
Number of subjects: 66
Study 32385867 — intervention group
Group type: EXPERIMENTAL
Intervention: Gauze soaked with 1:10 000 adrenaline
Number of subjects: 26
Study 32385867 — intervention group
Group type: COMPARATOR
Intervention: Gauze soaked with 2% lidocaine without adrenaline
Number of subjects: 26
Study 35575746 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) ingestion
Number of subjects: 12
Study 35575746 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 32342894 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal Simulation System with varying surface temperatures of shell materials
Number of subjects: 17
Study 32342894 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact duration with heated plates
Number of subjects: 17
Study 32342894 — intervention group
Group type: EXPERIMENTAL
Intervention: Different materials with varying thermal inertias
Number of subjects: 17
Study 35971069 — intervention group
Group type: EXPERIMENTAL
Intervention: Step function model fitted on data from all treatment arms
Number of subjects: 0
Study 35971069 — intervention group
Group type: EXPERIMENTAL
Intervention: Step function model
Number of subjects: 0
Study 35971069 — intervention group
Group type: EXPERIMENTAL
Intervention: Step function models
Number of subjects: 0
Study 36399083 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to self-selected music for 30 minutes daily for two weeks (Multi-Music Group - MG)
Number of subjects: 120
Study 36399083 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to lullabies for 30 minutes daily for two weeks (Lullaby Group - LG)
Number of subjects: 120
Study 36399083 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no music intervention
Number of subjects: 120
Study 32522060 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (beetroot juice + folate)
Number of subjects: 48
Study 32522060 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intervention (beetroot juice + placebo)
Number of subjects: 48
Study 32522060 — intervention group
Group type: COMPARATOR
Intervention: Control group (nitrate-depleted beetroot juice + placebo)
Number of subjects: 48
Study 32304277 — intervention group
Group type: EXPERIMENTAL
Intervention: Framingham Risk Score for Hypertension
Number of subjects: 8027
Study 32304277 — intervention group
Group type: EXPERIMENTAL
Intervention: ELSA-Brasil Risk Score
Number of subjects: 8027
Study 35587247 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandrax use
Number of subjects: 500
Study 36048417 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5‐nCoV (5 × 10^10 viral particles/vial, 0.5 mL)
Number of subjects: 1050
Study 36048417 — intervention group
Group type: EXPERIMENTAL
Intervention: Batch 3 of Ad5‐nCoV
Number of subjects: 1050
Study 36048417 — intervention group
Group type: COMPARATOR
Intervention: Batch 1 of Ad5‐nCoV
Number of subjects: 1050
Study 36048417 — intervention group
Group type: COMPARATOR
Intervention: Batch 2 of Ad5‐nCoV
Number of subjects: 1050
Study 33569869 — intervention group
Group type: EXPERIMENTAL
Intervention: Adventure therapy (AT)
Number of subjects: 0
Study 33569869 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (based on cognitive-behavioral therapy)
Number of subjects: 0
Study 32740449 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole treatment
Number of subjects: 858
Study 32740449 — intervention group
Group type: EXPERIMENTAL
Intervention: Douching at least once
Number of subjects: 858
Study 32740449 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who had sex with women (WSW)
Number of subjects: 858
Study 32740449 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >21 years
Number of subjects: 858
Study 35243620 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 476
Study 35243620 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 476
Study 35243620 — intervention group
Group type: COMPARATOR
Intervention: Control group (no childhood trauma history)
Number of subjects: 476
Study 32921587 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 279
Study 32921587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study 32770492 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in excessive alcohol consumption
Number of subjects: 0
Study 32770492 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute alcohol consumption
Number of subjects: 0
Study 32770492 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual alcohol consumption
Number of subjects: 0
Study 32770492 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol reduction and/or abstinence
Number of subjects: 0
Study 35367469 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure at concentrations of 20, 50, and 150 μg/m3 for 4 hours
Number of subjects: 13
Study 35367469 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure at concentrations of 50 μg/m3 and above
Number of subjects: 13
Study 35367469 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 13
Study 33745088 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBMT) - three irradiations at 808 nm, 100 mW, 142 J/cm2, and 4 J per site
Number of subjects: 44
Study 33745088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32372407 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 1: device-enhanced; Group 2: toothbrush)
Number of subjects: 36
Study 32372407 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 1: device-enhanced)
Number of subjects: 36
Study 32372407 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 2: toothbrush)
Number of subjects: 36
Study 32372407 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 1 and 2)
Number of subjects: 36
Study 35879013 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based treatment
Number of subjects: 262
Study 35879013 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 262
Study 34673258 — intervention group
Group type: EXPERIMENTAL
Intervention: Active anodal tDCS (a-tDCS) with DRG stimulation
Number of subjects: 16
Study 34673258 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with DRG stimulation
Number of subjects: 16
Study 34673258 — intervention group
Group type: COMPARATOR
Intervention: DRG stimulation alone
Number of subjects: 16
Study 34673258 — intervention group
Group type: EXPERIMENTAL
Intervention: M1 tDCS
Number of subjects: 16
Study 34673258 — intervention group
Group type: EXPERIMENTAL
Intervention: MEG-localized tDCS
Number of subjects: 16
Study 32604254 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CR plus hatha yoga
Number of subjects: 70
Study 32604254 — intervention group
Group type: COMPARATOR
Intervention: Standard CR
Number of subjects: 70
Study 34268908 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine with pantoprazole (40 mg once daily for 9 days)
Number of subjects: 24
Study 34268908 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine without pantoprazole
Number of subjects: 24
Study 33874800 — intervention group
Group type: EXPERIMENTAL
Intervention: Short trial - 20-minutes of HIIE, 30-second efforts at 100% of MAP interspersed by 30-seconds of passive recovery
Number of subjects: 30
Study 33874800 — intervention group
Group type: EXPERIMENTAL
Intervention: Long trial - 20-minutes of the short trial plus 10-minutes more of HIIE, decreasing 3% of MAP in each additional bout
Number of subjects: 30
Study 33874800 — intervention group
Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 30
Study 36071424 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glycemic control (TGC)
Number of subjects: 269
Study 36071424 — intervention group
Group type: COMPARATOR
Intervention: Standard care treatment
Number of subjects: 269
Study 36071424 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe hypoglycemia
Number of subjects: 269
Study 36071424 — intervention group
Group type: COMPARATOR
Intervention: No to mild hypoglycemia
Number of subjects: 269
Study 35678946 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Communication Intervention
Number of subjects: 78
Study 35678946 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance families had to travel to the university
Number of subjects: 78
Study 32460589 — intervention group
Group type: EXPERIMENTAL
Intervention: G. sylvestre 300 mg b.i.d.
Number of subjects: 30
Study 32167045 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gripping ProGrip (PG) mesh
Number of subjects: 99
Study 32167045 — intervention group
Group type: COMPARATOR
Intervention: Sutured polypropylene (PL) mesh
Number of subjects: 99
Study 35503591 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 210
Study 35503591 — intervention group
Group type: COMPARATOR
Intervention: Nasal prongs
Number of subjects: 210
Study 35503591 — intervention group
Group type: COMPARATOR
Intervention: 4 hourly rotation of masks and prongs
Number of subjects: 210
Study 33645192 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40
Study 33645192 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 40
Study 33571477 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1878
Study 33571477 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1878
Study 32540383 — intervention group
Group type: EXPERIMENTAL
Intervention: PS-matched analysis
Number of subjects: 193620
Study 32540383 — intervention group
Group type: COMPARATOR
Intervention: Reduced RCTs
Number of subjects: 193620
Study 36199767 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal Tunnel Endoscopic Resection (STER)
Number of subjects: 272
Study 36199767 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic Mucosal Dissection (ESD)
Number of subjects: 272
Study 34051912 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized multiple-baseline designs
Number of subjects: 0
Study 34051912 — intervention group
Group type: EXPERIMENTAL
Intervention: Various randomization statistical tests
Number of subjects: 0
Study 34853089 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (approximately 6 mg/kg single intravenous infusion, then subcutaneous injections of 90 mg every 8 weeks)
Number of subjects: 102
Study 34853089 — intervention group
Group type: COMPARATOR
Intervention: Placebo (initially, then crossover to ustekinumab at week 24)
Number of subjects: 102
Study 32510144 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Orange Juice (BOJ)
Number of subjects: 15
Study 32510144 — intervention group
Group type: COMPARATOR
Intervention: Control Drink (CD)
Number of subjects: 15
Study 35394387 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal Dialysis (PD)
Number of subjects: 1082
Study 35394387 — intervention group
Group type: COMPARATOR
Intervention: Conventional in-centre Haemodialysis (HD)
Number of subjects: 1082
Study 34605384 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support group (PSG)
Number of subjects: 75
Study 34605384 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietician-led support group (DSG)
Number of subjects: 75
Study 34605384 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal support group (MSG)
Number of subjects: 75
Study 34605384 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 75
Study 36008059 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 85
Study 36008059 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 85
Study 33275764 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with Pst
Number of subjects: 2
Study 33275764 — intervention group
Group type: EXPERIMENTAL
Intervention: CSEP Unigene17495 (PSTG 10917)
Number of subjects: 2
Study 32566685 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 95
Study 32566685 — intervention group
Group type: COMPARATOR
Intervention: Humalog Mix25
Number of subjects: 95
Study 36252683 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming (EXE)
Number of subjects: 22
Study 36252683 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CON)
Number of subjects: 22
Study 32880201 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal Jelly (RJ) supplementation (3000 mg of fresh RJ equivalent)
Number of subjects: 72
Study 32880201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 32833495 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain placement during surgery
Number of subjects: 148260
Study 32833495 — intervention group
Group type: COMPARATOR
Intervention: No drain placement during surgery
Number of subjects: 148260
Study 35932444 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical additional ablation (EAA)
Number of subjects: 0
Study 35932444 — intervention group
Group type: COMPARATOR
Intervention: Control group (limited single point ablation)
Number of subjects: 0
Study 32074648 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of naphthalan applications and non-selective Bioptron chromotherapy
Number of subjects: 64
Study 32074648 — intervention group
Group type: COMPARATOR
Intervention: Isolated effect of naphthalan
Number of subjects: 64
Study 33906810 — intervention group
Group type: EXPERIMENTAL
Intervention: MR‐proADM guided arm (low MR‐proADM value ≤0.87 nmol/L)
Number of subjects: 200
Study 33906810 — intervention group
Group type: EXPERIMENTAL
Intervention: MR‐proADM guided arm (high MR‐proADM value >0.87 nmol/L)
Number of subjects: 200
Study 33906810 — intervention group
Group type: EXPERIMENTAL
Intervention: MR‐proADM guided arm (per protocol population)
Number of subjects: 200
Study 33906810 — intervention group
Group type: COMPARATOR
Intervention: Control arm (Standard Care)
Number of subjects: 200
Study 32128844 — intervention group
Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in healthy elderly (55-65 years, 66-75 years, >75 years) dosed B.D. for 4 days
Number of subjects: 73
Study 32128844 — intervention group
Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in healthy elderly (>75 years) dosed B.D. for 4 days
Number of subjects: 73
Study 32128844 — intervention group
Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in mild renal impairment dosed B.D. for 8 days
Number of subjects: 73
Study 32128844 — intervention group
Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in moderate renal impairment dosed O.D. for 8 days
Number of subjects: 73
Study 32128844 — intervention group
Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in severe renal impairment (no dialysis) dosed once every 48h for 8 days
Number of subjects: 73
Study 34215144 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Transcranial Magnetic Stimulation (dTMS) to the right prefrontal cortex (rPFC)
Number of subjects: 62
Study 34215144 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Transcranial Magnetic Stimulation (dTMS) to the left prefrontal cortex (lPFC)
Number of subjects: 62
Study 34215144 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 62
Study 36434823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 15 mmHg
Number of subjects: 40
Study 36434823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 12 mmHg
Number of subjects: 40
Study 36434823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 10 mmHg
Number of subjects: 40
Study 36434823 — intervention group
Group type: COMPARATOR
Intervention: Pneumoperitoneum pressures (12 mmHg and 10 mmHg)
Number of subjects: 40
Study 34416193 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 vaccine (two doses, 28 days apart)
Number of subjects: 174
Study 34416193 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 vaccine
Number of subjects: 174
Study 32408925 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecurity prevalence
Number of subjects: 212608
Study 32408925 — intervention group
Group type: EXPERIMENTAL
Intervention: Odds of food insecurity
Number of subjects: 212608
Study 32408925 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with sociodemographic factors
Number of subjects: 212608
Study 32408925 — intervention group
Group type: EXPERIMENTAL
Intervention: Income, smoking status, and self-rated health
Number of subjects: 212608
Study 32408925 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related increase in food insecurity
Number of subjects: 212608
Study 35964021 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimalist flexible footwear (MFG)
Number of subjects: 43
Study 35964021 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized insole on footwear (COIG)
Number of subjects: 43
Study 34192666 — intervention group
Group type: EXPERIMENTAL
Intervention: Open science dataset from PREVENT-AD cohort
Number of subjects: 386
Study 34192666 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal imaging data
Number of subjects: 386
Study 34192666 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive information
Number of subjects: 386
Study 32969200 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (n=12) received mesalazine (60 mg kg−1 day−1) and oral probiotics (Lactobacillus casei Zhang, Lactobacillus plantarum P‐8, Bifidobacterium animalis subsp. lactis V9) twice daily for 12 weeks
Number of subjects: 25
Study 32969200 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (n=13) received the same amounts of mesalazine and placebo
Number of subjects: 25
Study 32969200 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group
Number of subjects: 25
Study 36265219 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic cycling intervention (PDex, N = 14)
Number of subjects: 28
Study 36265219 — intervention group
Group type: COMPARATOR
Intervention: No intervention control group (PDcontrol, N = 14)
Number of subjects: 28
Study 33296553 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS) administered twice weekly for 24 weeks
Number of subjects: 27
Study 33296553 — intervention group
Group type: COMPARATOR
Intervention: Sham sonification
Number of subjects: 27
Study 33296553 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS)
Number of subjects: 27
Study 36374656 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-GAP + mHealth
Number of subjects: 51
Study 36374656 — intervention group
Group type: COMPARATOR
Intervention: mHealth only
Number of subjects: 51
Study 35892316 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrasentan (dosage not specified)
Number of subjects: 3329
Study 34010324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline
Number of subjects: 1060
Study 34010324 — intervention group
Group type: COMPARATOR
Intervention: Plasma-Lyte 148
Number of subjects: 1060
Study 32414901 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 99
Study 32414901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 36070308 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief mindfulness training (MT)
Number of subjects: 40
Study 36070308 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 40
Study 32466858 — intervention group
Group type: EXPERIMENTAL
Intervention: Senofilcon A lenses with polyquaternium-based care solution (OPTI-FREE Replenish)
Number of subjects: 0
Study 32006156 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-month ticagrelor monotherapy following 1-month dual antiplatelet therapy (DAPT)
Number of subjects: 15968
Study 32006156 — intervention group
Group type: COMPARATOR
Intervention: 12-month aspirin monotherapy following 12-month DAPT
Number of subjects: 15968
Study 35267097 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 ml 2% lidocaine + 0.4 ml (40 μg) dexmedetomidine (DEX)
Number of subjects: 50
Study 35267097 — intervention group
Group type: COMPARATOR
Intervention: 1.4 ml 2% plain lidocaine
Number of subjects: 50